All Articles

SAS tackles the AI privacy paradox with its new Data Maker, a strategic move to unlock innovation in regulated industries without risking sensitive data.

Janux Therapeutics is set to unveil key data for its cancer drug JANX007. The results could validate its precision platform and shake up the market.

A new AI-powered system has been cleared to detect life-threatening 'silent' seizures in newborns, a first-of-its-kind approval for all patient ages.

As scam calls cost consumers billions, NordVPN expands its call protection to the UK and Canada. Is this a game-changer or just another tool in the fight?

Corporación América Airports reports its highest-ever EBITDA, driven by traffic growth that outpaces rivals and bold new projects in Iraq and Angola.

A German court just handed InterDigital another win against Disney, highlighting the hidden patent costs that could reshape the economics of streaming.

Australian 'Neocloud' SHARON AI expands its massive Texas AI data center plan to 438 acres, betting big on the US market ahead of a complex public listing.

A $1.1B venture in Kazakhstan aims to control 15% of global tungsten, challenging market dominance and securing a critical US supply chain.

Versant Ventures' new startup, Dayra Therapeutics, secures a major Biogen deal, validating its platform to create pill-based biologics for immunology.

Canacol Energy's cross-border bankruptcy is more than a corporate failure; it's a critical stress test for international law and Colombia's fragile energy supply.

Facing a 74% stock drop and legal challenges, benefits giant Alight brings in an external CEO known for revenue growth to steer a difficult turnaround.

New data reveals a surge in US charity, driven not just by generosity, but by innovative tools like Donor-Advised Funds that amplify donor impact.

With the Cedar Fair merger complete, can new CEO John Reilly leverage his operational expertise to revive underperforming parks and win the theme park wars?

Elite universities are now adopting B2B marketing playbooks. See how Cambridge is using data-driven engagement tech to revolutionize MBA recruitment.

Liberty Defense taps a specialized partner for HEXWAVE deployment, a strategic move to overcome financial hurdles and accelerate growth in the security market.

With cash dwindling and Nasdaq warnings, Profusa bets its future on late-breaking clinical data for its revolutionary tissue-monitoring implant.

Inside a historic German wind tunnel, an unsung industrial hero is quietly accelerating the future of supersonic flight. Here’s how it works.

Day One's pediatric cancer drug OJEMDA offers more than hope; its unique treatment model signals a seismic shift in pharmaceutical logistics and operations.

The strategic acquisition merges advanced AI and workflow automation with compliance, aiming to shift the energy sector from reactive to predictive operations.

A new partnership for America's 250th anniversary goes beyond sponsorship, aiming to define the future of American ingenuity and honor its veteran innovators.